[go: up one dir, main page]

AU2002249304A8 - Novel human gnrh receptor - Google Patents

Novel human gnrh receptor

Info

Publication number
AU2002249304A8
AU2002249304A8 AU2002249304A AU2002249304A AU2002249304A8 AU 2002249304 A8 AU2002249304 A8 AU 2002249304A8 AU 2002249304 A AU2002249304 A AU 2002249304A AU 2002249304 A AU2002249304 A AU 2002249304A AU 2002249304 A8 AU2002249304 A8 AU 2002249304A8
Authority
AU
Australia
Prior art keywords
novel human
gnrh receptor
human gnrh
receptor
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249304A
Other versions
AU2002249304A1 (en
Inventor
Eric Ferrandis
Christophe Thurieau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0102802A external-priority patent/FR2821619A1/en
Priority claimed from FR0106760A external-priority patent/FR2825094A1/en
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of AU2002249304A1 publication Critical patent/AU2002249304A1/en
Publication of AU2002249304A8 publication Critical patent/AU2002249304A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002249304A 2001-03-01 2002-03-01 Novel human gnrh receptor Abandoned AU2002249304A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
FR01/02802 2001-03-01
FR0102802A FR2821619A1 (en) 2001-03-01 2001-03-01 NEW HUMAN GNRH RECEIVER
FR01/06763 2001-05-22
FR0106760A FR2825094A1 (en) 2001-05-22 2001-05-22 New isolated human gonadotropin-releasing hormone receptors and nucleic acids, useful for treating disorders associated with gonadal steroids, e.g. endometriosis
FR0106763 2001-05-22
FR01/06760 2001-05-22
PCT/FR2002/000741 WO2002070701A2 (en) 2001-03-01 2002-03-01 Novel human gnrh receptor

Publications (2)

Publication Number Publication Date
AU2002249304A1 AU2002249304A1 (en) 2002-09-19
AU2002249304A8 true AU2002249304A8 (en) 2007-08-30

Family

ID=27248748

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002249304A Abandoned AU2002249304A1 (en) 2001-03-01 2002-03-01 Novel human gnrh receptor

Country Status (2)

Country Link
AU (1) AU2002249304A1 (en)
WO (1) WO2002070701A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009631A2 (en) * 2002-07-22 2004-01-29 Bayer Healthcare Ag Human gnrh (type 2) receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2138999C (en) * 1992-06-23 2010-02-23 Stuart C. Sealfon Cloning and expression of gonadotropin-releasing hormone receptor
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
WO1997047743A1 (en) * 1996-06-13 1997-12-18 Zymogenetics, Inc. Human type ii gonadotropin-releasing hormone receptor
BR0110098A (en) * 2000-04-15 2003-01-14 Medical Res Council Polynucleotide, recombinant genetic construct, expression vector, host cell, transgenic animal, peptide, methods for screening an agent for pharmacological activity, inhibiting the binding of gnrh to its native receptor in vivo, and contraception, and uses of type ii gnrh-r or an extracellular domain thereof

Also Published As

Publication number Publication date
WO2002070701A3 (en) 2003-10-09
AU2002249304A1 (en) 2002-09-19
WO2002070701A9 (en) 2007-06-28
WO2002070701A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
GB0219559D0 (en) Early entry
GB0207457D0 (en) Early entry
DE60234426D1 (en) Multiplexer
GB0210122D0 (en) Early entry
GB0218205D0 (en) Human ZZAP1 protein
GB0318142D0 (en) Early entry
GB0207604D0 (en) Early entry
EP1373508A4 (en) Human cytokine receptor
GB0221500D0 (en) Early entry
GB0211234D0 (en) Early entry
IL162019A0 (en) Mousse
CA97201S (en) Napkin
GB0218610D0 (en) Early entry
AU2002367281A8 (en) Isolated cytokine receptor licr-2
GB0212672D0 (en) Early entry
AU2002249304A8 (en) Novel human gnrh receptor
GB0128122D0 (en) Therapeutic use
AU2003260313A8 (en) Human gnrh (type 2) receptor
GB0128161D0 (en) Receptor protein
GB0408136D0 (en) A human G protein coupled receptor
GB0111959D0 (en) Receptor
GB0114929D0 (en) Receptor
GB0110662D0 (en) Receptor
GB0125183D0 (en) Receptor
GB0130281D0 (en) Early Entry

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase